drugset / Trial / NCT01023321
First-in-Human Single Ascending and Multiple Dose of GLPG0555
RandomizedParallel-groupQuadruple-blind
Summary
The purpose of the study is to evaluate the safety and tolerability of single ascending (SAD) and multiple (MD) oral dose of GLPG0555 compared to placebo. Also, pharmacokinetics (PK) and pharmacodynamics (PD) of GLPG555 after single and multiple oral administration will be evaluated, and, if applicable, the maximum tolerated dose determined.
Timeline
- Start
- 2009-12
- Primary completion
- 2010-04
- Completion
- 2010-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GLPG0555 | Unknown | — | Oral |
Indications
No indication recorded.